Section Arrow
Quote
PRPH.NASDAQ
- ProPhase Labs
(Financial Status)
Quotes are at least 15-min delayed:2025/07/03 01:32 EDT
Last
 0.4037
+0.0217 (+5.68%)
Day High 
0.41 
Prev. Close
0.382 
1-M High
0.4085 
Volume 
875.14K 
Bid
0.395
Ask
0.4
Day Low
0.385 
Open
0.385 
1-M Low
0.324 
Market Cap 
15.87M 
Currency USD 
P/E -- 
%Yield 74.31 
10-SMA 0.36 
20-SMA 0.36 
50-SMA 0.34 
52-W High 3.74 
52-W Low 0.2179 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.14/-0.56
Enterprise Value
33.87M
Balance Sheet
Book Value Per Share
0.36
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.77M
Operating Revenue Per Share
1.89
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp5.23+0.15+2.95%879PE
BIAFbioAffinity Technologies0.29+0.0265+10.06%-- 
DHRDanaher Corp202.5+1.4+0.70%38.97PE
OPKOPKO Health1.34+0.01+0.75%-- 
TMOThermo Fisher Scientific427.76+6.29+1.49%24.72PE
Quotes are at least 15-min delayed：2025/07/03 01:32 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.